日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Europe

EU backs AstraZeneca COVID-19 vaccine as blood clot reviews continue

Updated: 2021-04-24 05:47
Share
Share - WeChat
[Photo/Agencies]

April 23 - Europe's drug regulator reiterated on Friday the benefits of AstraZeneca's COVID-19 vaccine outweigh any risks, delivering an assessment based on continuing reviews into rare blood clots to help countries determine the shot's use.

The renewed backing comes after several countries in the European Union and worldwide have limited the use of the vaccine, known as Vaxzevria. Denmark has stopped its use altogether, after possible links to clotting issues in combination with low platelet levels were confirmed.

The interim analysis by a committee of the European Medicines Agency (EMA) determined that serious side effects of rare blood clots are likely to occur in 1 out of 100,000 vaccinated people, the regulator said in a statement.

EMA officials said in a briefing the update on Friday was aimed at putting into context the data it has collected and analysed to help 27 EU member states work out how to use the shot based on their local situations.

The advantages of getting the vaccine increase with age and with any rise in infections rates, but the benefits were for now evident across all scenarios and ages, the officials said.

They said the recommendation may be subject to change because more data is being collected, and for instance not all EU member states had included the sex of the vaccine recipients in their data.

But Peter Arlett, head of EMA's data analytics and methods task force, said: "The benefit risk balance of the AstraZeneca vaccine is positive. It's preventing serious disease and saving lives."

Earlier this month, the EMA said it had found a possible link between AstraZeneca's coronavirus vaccine and a similar, rare blood clotting problem connected to the one from Johnson & Johnson which led to a small number of deaths.

There was not enough data on Vaxzevria from Europe to determine if blood clot risks with low blood platelets would differ with each dose of the vaccine, or to provide context on its benefits and risks with regards to gender, the EMA said.

Countries are also in the midst of determining whether to use J&J's vaccine over concerns about blood clots and U.S. regulators were meeting on Friday to consider whether it is safe to resume J&J injections.

Regulators have found these events occurred mostly in the brain and abdomen.

(Reporting by Pushkala Aripaka in Bengaluru, Ludwig Burger in Frankfurt, Alistair Smout and Keith Weir in London; Writing by Josephine Mason; Editing by Saumyadeb Chakrabarty and Sriraj Kalluvila, William Maclean)

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 国产精品热 | 在线播放国产精品 | 亚洲天堂久久 | 四虎影院新地址 | 国产精品毛片久久久久久久 | 日韩欧美视频一区二区在线观看 | 日韩免费在线视频 | 亚洲精品国产第一区二区多人 | 日韩欧美综合在线二区三区 | 久久一 | 男女进进出出动态图啪啪 | 久久一二区 | 成人毛片国产a | 色播在线播放 | 夜夜操夜夜骑 | 欧美在线视频一区二区三区 | 午夜欧美性欧美 | 91香蕉国产视频 | 我不卡在线 | 波多野结衣一区二区三区88 | 热久久久 | 亚洲国产精品综合久久 | 99热久久这里只有精品首页 | 午夜手机电影 | 一级片国语 | 91看大片 | 午夜欧美一区二区三区在线播放 | 日本黄在线观看免费播放 | 米奇777四色精品人人爽 | 天天色综合影视 | 奇米成人网 | 漂流教室免费观看韩国电影 | 久久人| 国产精品视频999 | www伊人| 久久久国产精品x99av | 国产亚洲精品久久久久久久软件 | 亚州毛色毛片免费观看 | 亚洲欧美视频一区 | 日本精品久久久一区二区三区 | 97超精品视频在线观看 |